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Abstract
Background: Proxy recruitment of patient participants through community pharmacies may be a valuable strategy
to maximise participation. This paper focuses on the feasibility of such a recruitment strategy for research involving
people who experience severe mental illness.
Methods: Fifty-three community pharmacies, including 50 ‘Research Ready’ pharmacies, were asked to recruit
people with severe mental illness for participation in research. Pharmacists were asked to provide participant
information to anyone presenting a prescription meeting specific criteria.
Results: Thirteen recruitment sites (25%) (from 4 distinct organisations) were approved to recruit patient
participants. Eighty-five percent (n = 11) failed to recruit any potential participants.
Conclusions: Proxy recruitment of people with severe mental illness through community pharmacies was
challenging with challenges in both pharmacy- and participant-recruitment. Further investigation into supporting
community pharmacists’ engagement with recruiting patients with SMI as research participants is required.
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Background
The importance of recruiting a diverse sample of research
participants must be balanced against the practical limita-
tions imposed by limited resources. In an attempt to reach
a balance between these two issues, the possibility of re-
cruitment activity being undertaken by people outside of
the immediate research team, such as by community phar-
macies (CPs), can be considered [1–3].
People who experience mental illness, or their carers,
are in regular contact with pharmacies which might
present a suitable option as a proxy recruitment site.
Previous research has reported on the feasibility of proxy
recruitment of people with a chronic health condition
through CPs [1].
Here, the pharmacy and participant recruitment chal-
lenges experienced in a UK-based study are reported.
This qualitative study involving semi-structured inter-
views aimed to determine participants’ perceptions of
the roles of community pharmacists in supporting medi-
cines optimisation for people who experience mental ill-
ness. This work is part of a programme of postgraduate
research looking at how pharmacists work with people
with mental illness.
Methods
Potential recruitment sites were initially sought from a
list of Royal Pharmaceutical Society (RPS)-accredited Re-
search Ready Pharmacies (RRPs), accessed through the
National Institute for Health Research Clinical Research
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Network: West Midlands (NIHR CRN:WM). The RRP
programme is an “online self-accreditation tool covering
the basic requirements for undertaking primary care re-
search in the UK” [4].
Fifty NIHR CRN:WM RRPs received study informa-
tion from CRN:WM gatekeeper pharmacists. Due to
poor RRP recruitment, we subsequently expanded to
pharmacies with which we had professional contacts.
Three additional pharmacies were subsequently con-
tacted this way and site visits were offered to all 53
pharmacies.
Pharmacists were asked to identify potential patient
participants based on prescribed medicines. No specific
guidance was provided regarding how pharmacists
should introduce the study to potential patient partici-
pants. Following expression of interest, potential patient
participants were contacted by the lead researcher to
discuss the study and confirm participation.
No incentive was offered to pharmacies, but a £10 gift
voucher plus expenses was offered to patient partici-
pants. Three months were originally allowed for the re-
cruitment of research participants.
Results
Pharmacy recruitment
Research Ready Pharmacies received study information
via email, phone or site visit. Where no response was re-
ceived, at least one further contact was made. Four ex-
pressions of interest resulted from three independent
pharmacies and a chain of 10 premises (on behalf of
which interest was expressed by a single employee re-
sponsible for the chain’s involvement in research).
The lead researcher met with pharmacists from two of
the three independent pharmacies to discuss the study
and contacted the third by telephone. A meeting was
also held with a single representative for the chain of
pharmacies. Following this, recruitment site approval
was granted for one of the independent pharmacies and
each premises in the chain. The remaining two inde-
pendent premises withdrew from contact. Twenty two
per cent (11/50) of CRN:WM-linked RRPs participated
in the study; falling to 4% (2/50) if the chain of pharma-
cies for whom expression of interest was received from a
single individual, is considered a single entity.
Following extension to the ethical approval, study in-
formation was distributed to three further pharmacies
via professional contacts. Two were subsequently
granted site approval. Finally, study details were sent to
the Birmingham and Solihull Local Pharmaceutical
Committee for distribution to members but no expres-
sions of interest by pharmacies were received.
The mean time taken for site approval for each
recruiting pharmacy (n = 13) from the date of ethics ap-
proval was 62 days (range 31–102).
Participant recruitment
Six potential patient participants expressed interest in
study participation arising from two pharmacies; one
RRP and one pharmacy approached via professional con-
tacts. Eleven sites (85%) failed to recruit any potential
patient participants. Email contact was maintained
throughout the recruitment phase, with repeated offers
of support or face-to-face meetings. Recruitment was
closed after 12 months.
Patient retention rate from expression of interest to
interview completion was 50% (n = 3). Expressions of
interest from patients were received on average 21 days
(range 7–31, n = 6) following site approval and average
time to interview completion was 49 days (range 31–62,
n = 3).
Discussion
Recruiting patients with mental illness through CPs was
reliant on the willingness and capacity of pharmacists to
support the research. In this study, this strategy was in-
effective, despite literature support for the method [1, 2,
5]. The local RRP network was of limited value in terms
of recruitment and patient recruitment was curtailed
after 12 months; four times the planned duration. Where
RRP networks are used in future, simultaneous employ-
ment of additional strategies such as use of professional
contacts and snowballing may enhance recruitment.
Personal contact between the research team and the
recruitment site may be beneficial in terms of the com-
mitment subsequently demonstrated by that site [6]. A
limited number of pharmacies accepted our offers of a
personal visit. Although these appeared well received,
they did not correlate with subsequent recruitment
success.
Pharmacies may have struggled to identify potential
patient participants. Initial meetings with pharmacists
were promising, with pharmacists suggesting that they
could easily identify potential participants. However,
85% (11/13) were unable to recruit any patients. Two
pharmacists fed back that they had not identified anyone
fitting the inclusion criteria over the 12-month recruit-
ment period.
Research has highlighted ambivalence or even negative
views amongst community pharmacists regarding their
willingness to prioritise research during working hours
[5]. This may be exacerbated by a lack of confidence in
their knowledge and skills in working with people with
mental illness [7–9] or conscious or unconscious stigma-
tised views of people with mental illness [10]. Such
stigma may affect the ability of pharmacists to build rela-
tionships with people with SMI, making it less likely that
they would approach them for recruitment to research.
These two factors together may create a barrier to re-
search and, perhaps more importantly, to community
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pharmacy-led mental health clinical and supply services.
Improvement to recruitment efficiency is critical but
may not be plausible in the way described here until the
community pharmacy workforce feels better equipped to
develop meaningful relationships with people experien-
cing SMI.
Having the researcher physically present in community
pharmacies might have helped to overcome some of
these potential barriers by obviating the need for proxy
recruitment [11] and because they would be ideally
placed to promote the study. Such direct recruitment in
a Danish study within pharmacies resulted in high par-
ticipant recruitment (108 interviews), but used 58 phar-
macy interns as the researchers to achieve this [12].
Amending the recruitment strategy in this way has clear
resource implications.
Reluctance to refer people for inclusion in research
has been attributed to lack of confidence and skill as
well as misconceptions about the research [13]. Add-
itionally, community pharmacists may have overesti-
mated their capacity for engagement in research [4] or
misunderstood the selection criteria thus reducing the
number of potential participants approached [2]. Such
factors may have contributed to the poor recruitment.
Therefore, offering education and training to clinicians
may benefit study recruitment [6]. With greater re-
sources, it might have been possible to bolster pharmacy
recruitment by arranging a study launch meeting for
community pharmacists, personal visits to each potential
recruitment site, offering brief training on the treatment
of SMI or the payment of incentives to the pharmacy for
each completed interview [1].
Limitations
The study described here was limited to a single geo-
graphical region in the UK.
Since the aim of the underpinning research was differ-
ent to that of this report, some data which may be of
value are not available as they were not collected. For
example, the number of recruitment packs handed out
and the previous research experience of the pharmacies.
Recruitment might have been enhanced had pharmacy
technicians been included in the method but this was
not addressed in this study. Finally, the barriers to re-
cruitment might have been better elucidated by collect-
ing qualitative data from pharmacies who chose not to
engage or who were unable to recruit any participants,
and from patients who did not participate.
Conclusions
This study highlights potential difficulty in recruiting re-
search participants with severe mental illness by proxy
through their community pharmacies. Researchers con-
sidering proxy recruitment strategies for their studies
are encouraged to consider the difficulties described
here. For proxy recruitment strategies to be effective, a
personal relationship between the researcher and the re-
cruiters with ongoing personal contact between the two
parties appears vital. Future research should focus on
how community pharmacists can be better supported to
engage with research as part of their day-to-day practice
and on supporting them to work with people with SMI
in the research context.
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